Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coordination Complexes | 7 | 2026 | 28 | 2.360 |
Why?
|
| Heterocyclic Compounds | 6 | 2024 | 15 | 1.230 |
Why?
|
| Receptors, CXCR4 | 8 | 2024 | 29 | 1.050 |
Why?
|
| Organometallic Compounds | 4 | 2026 | 42 | 0.850 |
Why?
|
| Chelating Agents | 3 | 2019 | 22 | 0.590 |
Why?
|
| Aza Compounds | 2 | 2015 | 11 | 0.570 |
Why?
|
| Macrocyclic Compounds | 3 | 2014 | 7 | 0.550 |
Why?
|
| Antimalarials | 2 | 2014 | 25 | 0.530 |
Why?
|
| Schistosomicides | 1 | 2016 | 1 | 0.500 |
Why?
|
| Schistosomiasis mansoni | 1 | 2016 | 7 | 0.500 |
Why?
|
| Schistosoma mansoni | 1 | 2016 | 13 | 0.500 |
Why?
|
| Quinolines | 1 | 2016 | 35 | 0.490 |
Why?
|
| Aspartic Acid | 1 | 2016 | 52 | 0.490 |
Why?
|
| Copper | 1 | 2016 | 49 | 0.480 |
Why?
|
| Zinc | 1 | 2016 | 63 | 0.470 |
Why?
|
| Metals, Heavy | 1 | 2015 | 15 | 0.460 |
Why?
|
| Pyridines | 2 | 2019 | 108 | 0.450 |
Why?
|
| Transition Elements | 1 | 2015 | 2 | 0.450 |
Why?
|
| Ethylenes | 1 | 2015 | 5 | 0.450 |
Why?
|
| Alkanes | 1 | 2015 | 36 | 0.450 |
Why?
|
| Antioxidants | 2 | 2026 | 225 | 0.420 |
Why?
|
| Plasmodium falciparum | 1 | 2014 | 19 | 0.420 |
Why?
|
| Molecular Structure | 5 | 2026 | 246 | 0.380 |
Why?
|
| Iron | 2 | 2026 | 118 | 0.340 |
Why?
|
| Hydrogen Peroxide | 2 | 2026 | 146 | 0.290 |
Why?
|
| Catalysis | 3 | 2026 | 134 | 0.280 |
Why?
|
| Crystallography, X-Ray | 4 | 2016 | 223 | 0.260 |
Why?
|
| Salicylates | 1 | 2026 | 5 | 0.240 |
Why?
|
| Structure-Activity Relationship | 3 | 2016 | 209 | 0.240 |
Why?
|
| Ligands | 2 | 2016 | 178 | 0.220 |
Why?
|
| Oxidation-Reduction | 2 | 2015 | 381 | 0.210 |
Why?
|
| Kinetics | 2 | 2026 | 553 | 0.160 |
Why?
|
| Protein Binding | 3 | 2019 | 667 | 0.160 |
Why?
|
| Copper Radioisotopes | 1 | 2019 | 2 | 0.150 |
Why?
|
| Drug Discovery | 2 | 2016 | 37 | 0.150 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2016 | 34 | 0.150 |
Why?
|
| Cell Survival | 2 | 2026 | 420 | 0.150 |
Why?
|
| Models, Molecular | 3 | 2015 | 453 | 0.140 |
Why?
|
| Benzylamines | 4 | 2024 | 19 | 0.130 |
Why?
|
| Cercaria | 1 | 2016 | 1 | 0.130 |
Why?
|
| Praziquantel | 1 | 2016 | 2 | 0.130 |
Why?
|
| Cations, Divalent | 1 | 2016 | 14 | 0.120 |
Why?
|
| Manganese | 1 | 2016 | 24 | 0.120 |
Why?
|
| Electrochemistry | 1 | 2015 | 14 | 0.120 |
Why?
|
| Chemokine CXCL12 | 1 | 2015 | 9 | 0.110 |
Why?
|
| Electrochemical Techniques | 1 | 2015 | 22 | 0.110 |
Why?
|
| Parasitic Sensitivity Tests | 1 | 2014 | 1 | 0.110 |
Why?
|
| Vero Cells | 1 | 2014 | 12 | 0.110 |
Why?
|
| Trace Elements | 1 | 2014 | 8 | 0.110 |
Why?
|
| Chloroquine | 1 | 2014 | 9 | 0.110 |
Why?
|
| Drug Resistance | 1 | 2014 | 42 | 0.100 |
Why?
|
| Interleukins | 1 | 2015 | 112 | 0.100 |
Why?
|
| Animals | 4 | 2019 | 10756 | 0.100 |
Why?
|
| Cell Movement | 1 | 2015 | 377 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 612 | 0.090 |
Why?
|
| Nickel | 1 | 2012 | 15 | 0.090 |
Why?
|
| Mice | 2 | 2019 | 4845 | 0.080 |
Why?
|
| Anti-HIV Agents | 2 | 2009 | 20 | 0.080 |
Why?
|
| Metals | 1 | 2009 | 41 | 0.070 |
Why?
|
| Signal Transduction | 1 | 2015 | 1482 | 0.070 |
Why?
|
| Zinc Acetate | 1 | 2006 | 2 | 0.060 |
Why?
|
| Lactams, Macrocyclic | 1 | 2006 | 26 | 0.060 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2006 | 52 | 0.060 |
Why?
|
| Ethylenediamines | 1 | 2026 | 3 | 0.060 |
Why?
|
| Reactive Oxygen Species | 1 | 2026 | 299 | 0.050 |
Why?
|
| Female | 2 | 2019 | 15740 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 1360 | 0.050 |
Why?
|
| HIV-1 | 2 | 2012 | 59 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2019 | 90 | 0.040 |
Why?
|
| Humans | 5 | 2026 | 29078 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2019 | 137 | 0.040 |
Why?
|
| Radiopharmaceuticals | 1 | 2019 | 75 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2019 | 101 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2019 | 333 | 0.040 |
Why?
|
| Cell Line | 2 | 2012 | 701 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2019 | 254 | 0.030 |
Why?
|
| Liver | 1 | 2019 | 493 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2015 | 106 | 0.030 |
Why?
|
| Calibration | 1 | 2014 | 29 | 0.030 |
Why?
|
| Reference Standards | 1 | 2014 | 57 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 83 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2014 | 131 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 198 | 0.030 |
Why?
|
| Linear Models | 1 | 2014 | 204 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 158 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 105 | 0.030 |
Why?
|
| Gene Expression | 1 | 2015 | 417 | 0.020 |
Why?
|
| Lipids | 1 | 2014 | 220 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 472 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 788 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2012 | 114 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 360 | 0.020 |
Why?
|
| Eukaryota | 1 | 1990 | 19 | 0.020 |
Why?
|
| Mouth Mucosa | 1 | 1990 | 16 | 0.020 |
Why?
|
| Lasers | 1 | 1990 | 68 | 0.020 |
Why?
|
| Microscopy | 1 | 1990 | 38 | 0.020 |
Why?
|
| Spinal Cord | 1 | 1990 | 214 | 0.020 |
Why?
|
| HIV-2 | 1 | 2006 | 2 | 0.020 |
Why?
|
| Microcomputers | 1 | 1990 | 4 | 0.000 |
Why?
|
| Cats | 1 | 1990 | 52 | 0.000 |
Why?
|
| Microscopy, Fluorescence | 1 | 1990 | 163 | 0.000 |
Why?
|